The Complex Strategic Landscape for Precision Medicine: Cost, Convergence, Culture, Computing and Creative Destruction
View more...
The Precision Medicine Initiative at Merck: State-of-the-Art Patient 68 Selection
View more...
Why diagnostic companies need to control their own market.
View more...
FDA and Precision Medicine 2017- An Interim Report from Washington
View more...
A conversation with Stephen J. Ubl President and CEO of PhRMA
View more...
Propelling Medicine into the Digital Age
View more...
California Paves the Way for State Efforts in Precision Medicine
View more...
Emerging Models for Clinical Adoption of Personalized Medicine
View more...
Understanding and Managing Stress: Perspectives from in vivo Quantum Biology
View more...
How to Align the Moving Parts in Personalized Medicine Reimbursement
View more...
Personalis Wins New Contract to Sequence >34,000 Whole Human Genomes for the VA’s Million Veteran Program

Personalis Wins New Contract to Sequence >34,000 Whole Human…

Personalis, Inc., a provider of advanced genomic sequencing and analytics for immuno-oncology, today announced a new contract…

Read More...
Precision Medicine Meets Single-Cell DNA Analysis with Mission Bio

Precision Medicine Meets Single-Cell DNA Analysis with Mission…

Mission Bio, Inc., a pioneer in single-cell DNA analysis, recently announced it has secured $10 million in Series A funding.…

Read More...
Natera Chosen for Longitudinal Circulating Tumour DNA Study in Breast Cancer

Natera Chosen for Longitudinal Circulating Tumour DNA Study…

Natera, Inc., (NASDAQ: NTRA), a global leader in cell-free DNA testing, has entered into a research collaboration with Imperial…

Read More...
PAREXEL and Microsoft Form Cloud Technology Alliance Aimed at Accelerating the Pace of Drug Development

PAREXEL and Microsoft Form Cloud Technology Alliance Aimed at…

PAREXEL International Corp., a leading global biopharmaceutical services organization, and Microsoft Corp. announced a technology…

Read More...
The Comprehensive Cancer Center Innsbruck Joins Caris Life Sciences’ Precision Oncology Alliance as First International Member

The Comprehensive Cancer Center Innsbruck Joins Caris Life Sciences’…

Caris Life Sciences®,a leading innovator in molecular science focused on fulfilling the promise of precision medicine,…

Read More...
BERG Enters Into an Agreement With Sanofi Pasteur to Identify Biomarkers of Flu Vaccine Performance

BERG Enters Into an Agreement With Sanofi Pasteur to Identify…

BERG, a biopharmaceutical company that merges biology with technology, today announced a new research effort with Sanofi…

Read More...
BioRad November 2017 – Sideline

Video

Precision Medicine at Notre Dame

Notre Dame building a premier precision medicine group...

Read More...

The Power of Research

Cancer Research UK - bringing the power of research to everyone...

Read More...

Value of Medical Innovation

Medical innovation is a virtuous cycle that relies on investments from all stakeholders, patient access to treatment, and…

Read More...

Biogen Idec is Biogen, Once Again

One of the original biotech companies, Biogen has been anchored in Cambridge, MA for nearly four decades. Today, we remain…

Read More...

Novartis Targets Cancer Genomics for Precision Medicine

Go behind the scenes of the Next Generation Diagnostics group at the Novartis Institutes for BioMedical Research, and learn…

Read More...

Early Diagnosis of Genetic Diseases

Parabase Genomics is a privately held molecular diagnostics company focused on changing the way newborns and children with…

Read More...

 Tweets

 Blogs

Real “health care” happens when telemedicine is closely joined to a connected-care delivery model...

What are the factors driving change within the Autoimmune Disease IVD market? Autoimmune diseases...

As scientific progression continues its march forward, the word ‘separation’ is something that we...